The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Diagnosis and Management of Type 2 Diabetic Kidney Disease
Open accessAbstract
Type 2 diabetic kidney disease (DKD) is the most common cause of CKD and ESRD worldwide, and carries with it enormous human and societal costs. The goal of this review is to provide an update on the diagnosis and management of DKD based on a comprehensive review of the medical literature. Topics addressed include the evolving presentation of DKD, clinical differentiation of DKD from non-DKD, a state-of-the-art evaluation of current treatment strategies, and promising emerging treatments. It is expected that the review will help clinicians to diagnose and manage patients with DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Kramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618
Antihypertensive Therapy in the Presence of Proteinuria
Sarafidis, P. A., Khosla, N., & Bakris, G. L. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.014 · Cited by 364
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Pohl, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090763 · Cited by 322
(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70156-1 · Cited by 319
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Perkovic, V., Heerspink, H. L., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M. E., Hamet, P., Marre, M., et al. (2013) · Kidney International · doi:10.1038/ki.2012.401 · Cited by 316
The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
Sharma, S. G., Bomback, A. S., Radhakrishnan, J., Herlitz, L. C., Stokes, M. B., Markowitz, G. S., & D'Agati, V. D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02510213 · Cited by 315
de Zeeuw, D., Coll, B., Andress, D., Brennan, J. J., Tang, H., Houser, M., Correa-Rotter, R., Kohan, D., Lambers Heerspink, H. J., Makino, H., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080830 · Cited by 302
Groop, P.-H., Cooper, M. E., Perkovic, V., Emser, A., Woerle, H.-J., & von Eynatten, M. (2013) · Diabetes Care · doi:10.2337/dc13-0323 · Cited by 294
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
Penno, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Zerbini, G., Trevisan, R., Vedovato, M., Gruden, G., Cavalot, F., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283495cd6 · Cited by 270
Bailey, R. A., Wang, Y., Zhu, V., & Rupnow, M. F. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-415 · Cited by 247
Thomas, M. C., MacIsaac, R. J., Jerums, G., Weekes, A., Moran, J., Shaw, J. E., & Atkins, R. C. (2009) · Diabetes Care · doi:10.2337/dc08-2186 · Cited by 214
Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism
Sasser, J. M., Sullivan, J. C., Hobbs, J. L., Yamamoto, T., Pollock, D. M., Carmines, P. K., & Pollock, J. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030208 · Cited by 193
Bariatric surgery is associated with improvement in kidney outcomes
Chang, A. R., Chen, Y., Still, C., Wood, G. C., Kirchner, H. L., Lewis, M., Kramer, H., Hartle, J. E., Carey, D., Appel, L. J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.039 · Cited by 187
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
Bakris, G. L., & Molitch, M. (2014) · Diabetes Care · doi:10.2337/dc13-1870 · Cited by 186
Cornel, J. H., Bakris, G. L., Stevens, S. R., Alvarsson, M., Bax, W. A., Chuang, L.-M., Engel, S. S., Lopes, R. D., McGuire, D. K., Riefflin, A., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1415 · Cited by 186
Prevalence of Nondiabetic Renal Disease in Diabetic Patients
Pham, T. T., Sim, J. J., Kujubu, D. A., Liu, I.-L. A., & Kumar, V. A. (2007) · American Journal of Nephrology · doi:10.1159/000102598 · Cited by 176
Dwyer, J. P., Parving, H., Hunsicker, L. G., Ravid, M., Remuzzi, G., Lewis, J. B., & for the DEMAND Investigators (2011) · Cardiorenal Medicine · doi:10.1159/000333249 · Cited by 155
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
Tone, A., Shikata, K., Matsuda, M., Usui, H. K., Okada, S., Ogawa, D., Wada, J., & Makino, H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.02.009 · Cited by 139
Chang, T. I., Park, J. T., Kim, J.-K., Kim, S. J., Oh, H. J., Yoo, D. E., Han, S. H., Yoo, T., & Kang, S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.017 · Cited by 115
Fioretto, P., Stefánsson, B. V., JOHNSSON, E. K., Cain, V. A., & Sjöström, C. D. (2016) · Diabetologia · doi:10.1007/s00125-016-4017-1 · Cited by 99
Ismail‐Beigi, F., Craven, T. E., O’Connor, P. J., Karl, D. M., Calles-Escandón, J., HRAMIAK, I. M., GENUTH, S. M., Cushman, W. C., Gerstein, H. C., Probstfield, J. L., et al. (2011) · Kidney International · doi:10.1038/ki.2011.415 · Cited by 69
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease?
Friedman, A. N., & Wolfe, B. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07670715 · Cited by 65
Self-citationHeerspink, H. J. L., Persson, F., Brenner, B. M., Chaturvedi, N., Brunel, P., McMurray, J. J. V., Desai, A. S., Solomon, S. D., Pfeffer, M. A., PARVING, H.-H. D., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00469-6 · Cited by 50
Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
Palevsky, P. M., Zhang, J. H., Seliger, S. L., Emanuele, N., Fried, L. F., & Study, F. T. V. N.-D. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03470316 · Cited by 42
Schievink, B., de Zeeuw, D., Smink, P. A., Andress, D. L., Brennan, J. J., Coll, B., Correa‐Rotter, R., Hou, F. F., Kohan, D. E., Kitzman, D. W., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315598709 · Cited by 35
Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy
Bermejo, S., Soler, M. J., Gimeno, J., Barrios, C., Rodríguez, E., Mojal, S., & Pascual, J. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.11.013 · Cited by 25
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Tang, G., Li, S., Zhang, C., Chen, H., Wang, N., & Feng, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.020 · Cited by 364
Gupta, S., Dominguez, M., & Golestaneh, L. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.004 · Cited by 337
Xiang, E., Han, B., Zhang, Q., Rao, W., Wang, Z., Chang, C., Zhang, Y., Tu, C., Li, C., & Wu, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01852-y · Cited by 331
Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Yang, J., & Liu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816400 · Cited by 281
Metadata
- Authors
- Doshi, S. M., & Friedman, A. N.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-03-09
- Volume
- 12
- Issue
- 8
- Pages
- 1366-1373
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2594748846
- Cited by
- 344
- References
- 48
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.